Table 2. Response to treatment at 3, 6,... | American Society of Hematology

Table 2.

Response to treatment at 3, 6, and 12 months after initial treatment

	VSAA group	G-CSF+ group	G-CSF>roup	P value G-CSF+ group vs G-CSF− group
3 months
Numbers evaluable	46	33	31
CR	4 47%	5 39%	1 53%	0.21
PR	17 ]	8 ]	16 ]
NR	25	20	14
Alive	24	19	14
Dead	1	1	0
6 months
Numbers evaluable	45	33	31
CR	14 71%	8 55%	10 77%	0.18
PR	18 ]	10 ]	14 ]
NR	13	15	7
Alive	10	14	7
Dead	3	1	0
12 months
Numbers evaluable	44	30	30
CR	22 73%	11 60%	13 70%	0.59
PR	10 ]	7 ]	8 ]
NR	12	12	9
Alive	9	10	9
Dead	3	2	0

	VSAA group	G-CSF+ group	G-CSF>roup	P value G-CSF+ group vs G-CSF− group
3 months
Numbers evaluable	46	33	31
CR	4 47%	5 39%	1 53%	0.21
PR	17 ]	8 ]	16 ]
NR	25	20	14
Alive	24	19	14
Dead	1	1	0
6 months
Numbers evaluable	45	33	31
CR	14 71%	8 55%	10 77%	0.18
PR	18 ]	10 ]	14 ]
NR	13	15	7
Alive	10	14	7
Dead	3	1	0
12 months
Numbers evaluable	44	30	30
CR	22 73%	11 60%	13 70%	0.59
PR	10 ]	7 ]	8 ]
NR	12	12	9
Alive	9	10	9
Dead	3	2	0

CR, complete response; PR, partial response; NR, no response.